adenosine monophosphate has been researched along with Chronic Lung Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XW; Jin, X; Li, X; Liu, FL; Qin, JR; Sun, J; Wang, JH; Wu, ML; Yan, QH; Zhao, JC; Zheng, YT | 1 |
| Babusis, D; Baric, RS; Bauer, L; Brown, AJ; Cihlar, T; Clarke, MO; Denison, MR; Feng, JY; Hogg, A; Jordan, R; Leist, SR; Montgomery, SA; Porter, D; Schäfer, A; Sellers, S; Sheahan, TP; Sims, AC; Spahn, JE; Won, J | 1 |
2 other study(ies) available for adenosine monophosphate and Chronic Lung Injury
| Article | Year |
|---|---|
Combinational benefit of antihistamines and remdesivir for reducing SARS-CoV-2 replication and alleviating inflammation-induced lung injury in mice.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Endothelial Cells; Histamine Antagonists; Inflammation; Lung Injury; Mice; Rodent Diseases; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2022 |
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Carboxylesterase; Coronavirus Infections; Drug Combinations; Drug Development; Female; Humans; Interferon-beta; Lopinavir; Lung Injury; Male; Mice; Mice, Knockout; Middle East Respiratory Syndrome Coronavirus; Ritonavir; Viral Load; Virus Replication | 2020 |